Castle Biosciences

Yahoo Finance • 2 days ago

Take the Zacks Approach to Beat the Markets: Castle Biosciences, Hamilton Insurance & Monster Beverage in Focus

Last week, major U.S. indexes ended the Christmas-shortened week higher, with the S&P 500 and the Dow attaining new record highs. The S&P 500, the Dow Jones Industrial Average and the tech-heavy Nasdaq Composite gained 0.75%, 0.72% and 0.7... Full story

Yahoo Finance • 14 days ago

Landmark Study Shows Combination of Castle Biosciences' DecisionDx®-UM and PRAME Outperforms Gene Mutation Analysis in Predicting Survival Outcomes in Uveal Melanoma

FRIENDSWOOD, Texas, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data from the largest prospective, multicente... Full story

Yahoo Finance • 22 days ago

Expert Melanoma Panel Recommends Castle Biosciences’ DecisionDx®-Melanoma as a Best-Practice Tool for Managing Patients with Melanoma

FRIENDSWOOD, Texas, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced the publication of an independent expert consensu... Full story

Yahoo Finance • last month

Castle Biosciences Earns a Houston Chronicle Top Workplaces Award for the Fifth Consecutive Year

FRIENDSWOOD, Texas, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has been recognized by the Houston Chroni... Full story

Yahoo Finance • 2 months ago

New Data Confirms Performance of DecisionDx®-Melanoma to Identify Patients with Less Than Five Percent Risk of Sentinel Lymph Node Positivity

FRIENDSWOOD, Texas, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data demonstrating the clinical value of its... Full story

Yahoo Finance • 2 months ago

Castle Biosciences to Present at the Piper Sandler 37th Annual Healthcare Conference

FRIENDSWOOD, Texas, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to pre... Full story

Yahoo Finance • 2 months ago

New Data at American College of Gastroenterology Annual Meeting Show TissueCypher® Provides Actionable Risk Insights that Influence Clinical Management and Prompt Risk-Aligned Intervention in Barrett’s Esophagus

FRIENDSWOOD, Texas, Oct. 26, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data demonstrating that its TissueCypher® Bar... Full story

Yahoo Finance • 2 months ago

New Analysis of 13,560 Patients Demonstrates DecisionDx®-Melanoma Stratifies Risk Across Histological Subtypes; Findings to be Presented at Fall Clinical Dermatology Conference

This new histological subtype data confirms DecisionDx-Melanoma’s clinical value across the spectrum of melanoma Castle Biosciences will also present validation data on its atopic dermatitis pipeline test FRIENDSWOOD, Texas, Oct. 24, 20... Full story

Yahoo Finance • 3 months ago

Castle Biosciences to Release Third Quarter 2025 Financial Results and Host Conference Call on Monday, Nov. 3, 2025

FRIENDSWOOD, Texas, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its financial results for th... Full story

Yahoo Finance • 3 months ago

Castle Biosciences’ Founder, President and CEO Derek Maetzold Honored with the CEO of the Year Award by The CEO Magazine

FRIENDSWOOD, Texas, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its founder, president and chief executive o... Full story

Yahoo Finance • 3 months ago

Castle Biosciences Named One of Newsweek’s America’s Greatest Companies 2025

FRIENDSWOOD, Texas, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, has been included in the inaugural 2025 America’s Greatest Compa... Full story

Yahoo Finance • 4 months ago

New Data at American Foregut Society's 2025 Annual Meeting Demonstrates TissueCypher® Can Detect High-Risk Barrett’s Esophagus Patients Not Identified by Pathology to Support Improved Care Decisions

FRIENDSWOOD, Texas, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that new data demonstrating the personalized ris... Full story

Yahoo Finance • 4 months ago

Castle Biosciences to Participate in Upcoming Investor Conferences

FRIENDSWOOD, Texas, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to pre... Full story

Yahoo Finance • 5 months ago

Here are the top movers in Tuesday's session.

Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top gainers and losers in today's session. [topmovers] GAINERS TICKER CHANGE COMMENT YMAB [h... Full story

Yahoo Finance • 5 months ago

Tuesday's session: top gainers and losers

Curious about what's happening in today's session? Check out the latest stock movements and price changes. [topmovers] TODAY'S TOP GAINERS TICKER CHANGE COMMENT YMAB [https://www.chartmill.com/stock/quote/YMAB/profile] 103.... Full story

Yahoo Finance • 5 months ago

Traders are paying attention to the gapping stocks in Tuesday's session.

The market is buzzing with gapping stocks on Tuesday. Let's uncover which stocks are experiencing notable gaps during today's session. [gap] TODAY'S GAP UP STOCKS TICKER CHANGE COMMENT SMXT [https://www.chartmill.com/stock/qu... Full story

Yahoo Finance • 5 months ago

These stocks are moving in today's pre-market session

The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today. [premarket] GAINERS TICKER CHANGE COMMENT AIP [https://www.chartmill.com/stock/quote/AIP/... Full story

Yahoo Finance • 5 months ago

Castle Biosciences raises 2025 revenue guidance to $310M–$320M following strong Q2 execution and test volume growth

Earnings Call Insights: Castle Biosciences (CSTL) Q2 2025 MANAGEMENT VIEW * Derek J. Maetzold, CEO, reported that the company “closed out a very successful second quarter that was ahead of our expectations,” citing revenue of $86.2 mil... Full story

Yahoo Finance • 5 months ago

Castle Biosciences Q2 2025 slides: Test volume surges 33% amid declining margins

Introduction & Market Context Castle Biosciences, Inc. (NASDAQ:CSTL) presented its Q2 2025 corporate results on August 4, 2025, highlighting strong test volume growth alongside declining margins and profitability metrics. The molecular di... Full story

Yahoo Finance • 5 months ago

Castle Biosciences to Present at the Canaccord Genuity 45th Annual Growth Conference

FRIENDSWOOD, Texas, July 29, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to pre... Full story